Skip to main content
SpringerLink
Log in

DM possible with antidepressants, plausible with antipsychotics

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Brown LC, Majumdar SR, Johnson JA.Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): S158, Aug 2007

  2. Brown LC, Johnson JA.Development of type 2 diabetes in patients taking atypical antipsychotic agents: a systematic review. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): S158-S159, Aug 2007

  3. Ulcickas Yood M, Delorenze G, Quesenberry Jr CP, L’Italien G, Oliveria SA, Tsai A-L, Campbell U, Willey V, McQuade R, Newcomer J.The incidence of diabetes in atypical antipsychotic users differs according to agent - results from a multisite epidemiologic study. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): S36-S37, Aug 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

DM possible with antidepressants, plausible with antipsychotics. React. Wkly. 1174, 3 (2007). https://doi.org/10.2165/00128415-200711740-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711740-00008

Keywords

Search

Navigation